Telo Genomics Corp Stock Analysis
| TELO Stock | CAD 0.11 0.01 8.33% |
Telo Genomics Corp is fairly valued with Real Value of 0.11 and Hype Value of 0.1. The main objective of Telo Genomics stock analysis is to determine its intrinsic value, which is an estimate of what Telo Genomics Corp is worth, separate from its market price. There are two main types of Telo Genomics' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Telo Genomics' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Telo Genomics' stock to identify patterns and trends that may indicate its future price movements.
The Telo Genomics stock is traded in Canada on TSX Venture Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in Canada. Telo Genomics is usually not traded on Canada Day, Civic Holiday, Labour Day, Christmas Day, Boxing Day, New Year 's Day, Family Day, Good Friday, Victoria Day. Telo Stock trading window is adjusted to America/Toronto timezone.
Telo |
Telo Stock Analysis Notes
The company recorded a loss per share of 0.04. Telo Genomics Corp last dividend was issued on the 22nd of November 2019. The entity had 1:5 split on the 22nd of November 2019. Telo Genomics Corp., a personalized medicine company, focuses on the development and commercialization of predictive technological products. The company was formerly known as 3D Signatures Inc. and changed its name to Telo Genomics Corp. in April 2019. TELO GENOMICS operates under Diagnostics Research classification in Canada and is traded on TSX Venture Exchange. To find out more about Telo Genomics Corp contact the company at 416 673 8487 or learn more at https://www.telodx.com.Telo Genomics Corp Investment Alerts
| Telo Genomics Corp generated a negative expected return over the last 90 days | |
| Telo Genomics Corp has high historical volatility and very poor performance | |
| Telo Genomics Corp has some characteristics of a very speculative penny stock | |
| Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years | |
| Telo Genomics Corp has accumulated 32.5 K in total debt. Telo Genomics Corp has a current ratio of 0.09, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Telo Genomics until it has trouble settling it off, either with new capital or with free cash flow. So, Telo Genomics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Telo Genomics Corp sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Telo to invest in growth at high rates of return. When we think about Telo Genomics' use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (2.82 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Telo Genomics Corp has accumulated about 24.25 K in cash with (2.63 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: Telo Genomics Secures 80K IP Grant, Expands TeloView Patent Protection to 2043 TDSGF Stock News - StockTitan |
Telo Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 8.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Telo Genomics's market, we take the total number of its shares issued and multiply it by Telo Genomics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Telo Profitablity
Telo Genomics' profitability indicators refer to fundamental financial ratios that showcase Telo Genomics' ability to generate income relative to its revenue or operating costs. If, let's say, Telo Genomics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Telo Genomics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Telo Genomics' profitability requires more research than a typical breakdown of Telo Genomics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.86) | (0.12) | |
| Return On Capital Employed | (4.61) | (0.13) | |
| Return On Assets | (2.81) | (0.12) | |
| Return On Equity | (4.60) | (0.12) |
Management Efficiency
Telo Genomics Corp has return on total asset (ROA) of (0.8732) % which means that it has lost $0.8732 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.6942) %, meaning that it generated substantial loss on money invested by shareholders. Telo Genomics' management efficiency ratios could be used to measure how well Telo Genomics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to climb to -0.12 in 2024. Return On Capital Employed is likely to climb to -0.13 in 2024. At this time, Telo Genomics' Total Assets are fairly stable compared to the past year. Total Current Assets is likely to climb to about 3.4 M in 2024, whereas Intangible Assets are likely to drop slightly above 520.3 K in 2024.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.01 | 0.13 | |
| Tangible Book Value Per Share | 0.01 | 0.13 | |
| Enterprise Value Over EBITDA | (4.65) | (2.42) | |
| Price Book Value Ratio | 22.38 | 7.00 | |
| Enterprise Value Multiple | (4.65) | (2.42) | |
| Price Fair Value | 22.38 | 7.00 | |
| Enterprise Value | 12.4 M | 4 M |
The management team at Telo Genomics has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Beta 1.037 | Return On Assets (0.87) | Return On Equity (1.69) |
Technical Drivers
As of the 24th of November, Telo Genomics has the Risk Adjusted Performance of (0.10), variance of 35.21, and Coefficient Of Variation of (678.85). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Telo Genomics Corp, as well as the relationship between them. Please validate Telo Genomics Corp value at risk, skewness, and the relationship between the maximum drawdown and potential upside to decide if Telo Genomics is priced more or less accurately, providing market reflects its prevalent price of 0.11 per share.Telo Genomics Corp Price Movement Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Telo Genomics middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Telo Genomics Corp. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Telo Genomics Outstanding Bonds
Telo Genomics issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Telo Genomics Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Telo bonds can be classified according to their maturity, which is the date when Telo Genomics Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
Telo Genomics Predictive Daily Indicators
Telo Genomics intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Telo Genomics stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Telo Genomics Forecast Models
Telo Genomics' time-series forecasting models are one of many Telo Genomics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Telo Genomics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Telo Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Telo Genomics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Telo shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Telo Genomics. By using and applying Telo Stock analysis, traders can create a robust methodology for identifying Telo entry and exit points for their positions.
| Last Reported | Projected for Next Year |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Telo Genomics to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Additional Tools for Telo Stock Analysis
When running Telo Genomics' price analysis, check to measure Telo Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telo Genomics is operating at the current time. Most of Telo Genomics' value examination focuses on studying past and present price action to predict the probability of Telo Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telo Genomics' price. Additionally, you may evaluate how the addition of Telo Genomics to your portfolios can decrease your overall portfolio volatility.